Information Provided By:
Fly News Breaks for February 27, 2015
ZIOP
Feb 27, 2015 | 09:42 EDT
BMO Capital reports that Ziopharm says it's in talks with large pharma companies about optimizing the value of its CAR-T program. The firm quotes the company as saying that all business development options are on the table. The firm continues to believe that the market is underestimating the outlook of the company and its collaborators in CAR-T. It keeps a $15 price target and Outperform rating on the shares.
News For ZIOP From the Last 2 Days
There are no results for your query ZIOP
I agree to the thefly.com's disclaimer & terms of use
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.